MKI67 and neoplasm: Imprime’s establishment of this immuno-supportive microenvironment also allowed increased trafficking of activated cytotoxic T cells (CD8+/Ki67+/GrzB+) with effector phenotype (IFN-γ+/IL-2+/TNF-α+) into the tumor.